HOME >> MEDICINE >> NEWS
Media undermine efforts to tackle nicotine addiction

Inaccurate media reports surrounding the safety of new smoking cessation drugs are undermining the treatment of nicotine addiction, according to an editorial in this week's BMJ.

Professor Linda Ferry presents two scenarios that illustrate the struggle between the press and medical experts to investigate and report concerns about the safety of new drugs for smoking cessation, and the effect this struggle has on reported attempts to quit smoking.

In the United Kingdom, bupropion hydrochloride (Zyban) was heralded by the media as a wonder drug when it was released in 2000. Not surprisingly, smokers queued up in waiting rooms, expecting their tobacco addiction to be vanish with this new pill.

The public enthusiasm changed abruptly in February 2001 when a London newspaper profiled a few dramatic reports of deaths in smokers using bupropion. Although experts remain convinced of the safety of bupropion, the demand for treatment has declined.

A similar shift in public opinion followed media reports in the United States about an increased risk of heart attack associated with nicotine patches. A subsequent trial showed that patches were safe to use, specifically in patients with heart disease, but many smokers still believe the original media messages that if I use a patch and smoke even one cigarette, I might have a heart attack.

Clinicians should give clear messages to their patients that it is much safer to use either of these drugs to help their attempts to quit than to continue smoking, says the author. Unfortunately, much damage has been done.

Tobacco treatment specialists and public health agencies need to refute the inaccuracies of the media and present a clear picture of the enormous problem of preventable disability and the 120,000 tobacco related deaths a year from the 13 million smokers in the United Kingdom, she concludes.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
6-Jun-2002


Page: 1

Related medicine news :

1. Media update: GSA underscores hottest meeting topics
2. Media invitation first annual EDCTP Forum
3. Media invitation - European Society of Cardiology Congress 2004
4. Media invitation: The Movement Disorder Societys 7th International Congress
5. Media Advisory-- Results of California autism epidemiology study to be unveiled
6. Review of preliminary observations concludes the Mayo Clinic Natl Conf on Medicine and the Media
7. Media focus on endostatin helped -- not hurt --
8. Media advisory: Mayo Clinic study finds infliximab safe and beneficial for Crohns disease
9. Media coverage of new drugs is often misleading
10. Media advisory: Mayo Clinic study shows increased incidence of migraines in women
11. American Heart Association Media Advisory: Cholesterol Lowering Margarines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... , ... For more than fifty years, we've suffered whiplash as each new scientific study seemed ... the latest nutritional advice – advice that was supposed to keep us healthy and slim. ... American adults are considered to be overweight and more than 1 in 3 adults are ...
(Date:5/25/2016)... ... May 25, 2016 , ... "FCPX LUT Intense allows users ... footage," said Christina Austin - CEO of Pixel Film Studios. , With the ... easily add stylish color grades to their footage. A LUT is a Lookup Table ...
(Date:5/25/2016)... ... May 25, 2016 , ... Researchers from SUNY State College of Optometry ... work on visual evoked potential and human attention. The article, VEP and Human ... Diopsys® NOVA™ ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) ...
(Date:5/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... as the Medical Director of its new DeSoto facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Stern Environmental ... will be selling the device branded as Stern’s Real Time Monitoring (RTM) ... bedbugs to the hotel and motel industry, colleges for use in dormitories, shelters, and ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Mass. , May 24, 2016  NxStage Medical, ... technology company focused on advancing renal care, today announced ... plans to participate in the following schedule of investor ... be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, June ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... 24, 2016 Open Access Journal ... Neurophysiology  Elsevier , a world-leading provider ... today announced the launch of Clinical Neurophysiology ... that focuses on clinical practice issues in clinical neurophysiology. ... series, normal values and didactic reviews. It is an ...
Breaking Medicine Technology:
Cached News: